| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2008 | WO2008045566A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 04/17/2008 | WO2008045564A2 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 04/17/2008 | WO2008045559A2 Methods of treating oral mucositis |
| 04/17/2008 | WO2008045558A2 Benzothiadiazine compounds and their use |
| 04/17/2008 | WO2008045556A2 Novel synergistic opioid-cannabinoid codrug for pain management |
| 04/17/2008 | WO2008045543A1 Substituted 4h-imidazo [4, 5, 1-ij] [1, 6] naphthyridine-9-amines and their pharmaceutical use |
| 04/17/2008 | WO2008045529A1 Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| 04/17/2008 | WO2008045507A2 Substituted tetracycline compounds for treatment of bacillus anthracis infections |
| 04/17/2008 | WO2008045484A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | WO2008045473A1 Novel crystal of n-[[(5s)-3-[4-(2,6-dihydro-2-methylpyrolo[3,4-c] pyrazol-5(4h)-yl)-3-fluoropheny]-2-oxo-5-oxazolidinyl]methyl] acetamide |
| 04/17/2008 | WO2008045465A1 Omega-3 fatty acids and dyslipidemic agent for reduction of apo-b levels |
| 04/17/2008 | WO2008045461A2 Transdermal diethylstilbestrol for treating prostate cancer |
| 04/17/2008 | WO2008045410A2 Alcohol free formulation of argatroban |
| 04/17/2008 | WO2008045391A2 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
| 04/17/2008 | WO2008045382A2 A sealed photovoltaic apparatus |
| 04/17/2008 | WO2008045378A2 Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin |
| 04/17/2008 | WO2008045377A2 High-purity large-scale preparation of stannsoporfin |
| 04/17/2008 | WO2008045373A2 Stable antibody formulations |
| 04/17/2008 | WO2008045371A2 N-substituted-azacyclylamines as histamine-3 antagonists |
| 04/17/2008 | WO2008045358A1 Porphyrin catalysts and methods of use thereof |
| 04/17/2008 | WO2008045309A1 Stabilized prostaglandin e composition |
| 04/17/2008 | WO2008045294A2 Boosting immunity |
| 04/17/2008 | WO2008045273A2 Camkk(beta) as a target for treating obesity |
| 04/17/2008 | WO2008045268A2 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2008 | WO2008045267A2 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2008 | WO2008045266A2 Pyrazolopyrimidiwes as cyclin dependent kinase inhibitor |
| 04/17/2008 | WO2008045250A1 Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/17/2008 | WO2008045189A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 04/17/2008 | WO2008045186A1 Method of treatment of otitis externa |
| 04/17/2008 | WO2008045176A1 Use of tetracycline to treat lymphangioleiomyomatosis (lam) |
| 04/17/2008 | WO2008045170A2 Statin and omega-3 fatty acids for reduction of apo-b levels |
| 04/17/2008 | WO2008045060A1 Robust sustained release formulations |
| 04/17/2008 | WO2008045047A1 Robust sustained release formulations of oxymorphone and methods of use thereof |
| 04/17/2008 | WO2008045046A1 Robust sustained release formulations of oxymorphone |
| 04/17/2008 | WO2008045017A2 Sars and ebola inhibitors and use thereof, and methods for their discovery |
| 04/17/2008 | WO2008045006A1 Formulations of candesartan |
| 04/17/2008 | WO2008044928A1 Complement inhibition for improved nerve regeneration |
| 04/17/2008 | WO2008044903A1 Anti-cancer agent comprising 3,4-dihydroisoquinolinium salt derivative |
| 04/17/2008 | WO2008044862A1 Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory |
| 04/17/2008 | WO2008044848A1 A composition comprising an extract of rhei rhizoma or physcion compound isolated therefrom for treating or preventing cognitive dysfunction and the use thereof |
| 04/17/2008 | WO2008044787A1 Composition for treating cancer using dref as molecular target |
| 04/17/2008 | WO2008044782A2 Combination drug |
| 04/17/2008 | WO2008044777A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 04/17/2008 | WO2008044770A1 Agent for suppression of gastric emptying comprising 4-hydroxyisoleucine |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | WO2008044734A1 Aqueous liquid preparation comprising gatifloxacin |
| 04/17/2008 | WO2008044733A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/17/2008 | WO2008044731A1 N-phenyloxamidic acid derivative |
| 04/17/2008 | WO2008044729A1 Carboxylic acid derivative |
| 04/17/2008 | WO2008044704A1 Anti-cancer agent |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044691A1 Antidepressant agent |
| 04/17/2008 | WO2008044688A1 Urea derivative |
| 04/17/2008 | WO2008044659A1 Highly absorbable composition for oral administration containing oxidized coenzyme q10 |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008044632A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | WO2008044562A1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/17/2008 | WO2008044550A1 O/w/o-type emulsion containing lignan compound, and composition comprising the same |
| 04/17/2008 | WO2008044339A1 Therapeutic/preventive agent for intraocular disease containing statin compound |
| 04/17/2008 | WO2008044337A1 γ-GLOBIN INDUCER |
| 04/17/2008 | WO2008044336A1 Crystal-containing adhesive preparation |
| 04/17/2008 | WO2008044331A1 Solid preparation comprising ibuprofen and tranexamic acid |
| 04/17/2008 | WO2008044261A1 Use of amiodarone and amiodarone analogues as antiviral agents |
| 04/17/2008 | WO2008044127A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 04/17/2008 | WO2008044111A1 Pharmaceutical formulation tablet |
| 04/17/2008 | WO2008044102A1 Polymorph form of aprepitant and process for the preparation thereof |
| 04/17/2008 | WO2008044099A1 Charge transfer complexes in the treatment of inflammatory bowel diseases |
| 04/17/2008 | WO2008044054A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 04/17/2008 | WO2008044045A1 Pharmaceutical combinations |
| 04/17/2008 | WO2008044041A1 Pharmaceutical combinations |
| 04/17/2008 | WO2008044034A1 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 04/17/2008 | WO2008044033A1 Amide derivatives |
| 04/17/2008 | WO2008044029A1 Pharmaceutical combinations |
| 04/17/2008 | WO2008044022A1 Fused thiazole derivatives as kinase inhibitors |
| 04/17/2008 | WO2008043974A2 Two-compartment skincare products comprising ivermectin, and uses thereof |
| 04/17/2008 | WO2008043973A1 Dermatological composition containing avermictin nanocapsules, method for preparing the same and uses thereof |
| 04/17/2008 | WO2008043962A1 Novel morphine derivatives |
| 04/17/2008 | WO2008043857A2 Novel method of treatment of male sub-fertility |
| 04/17/2008 | WO2008043856A1 New composition for improving skin quality and a process for preparing the same |
| 04/17/2008 | WO2008043840A2 Anti-infective thiourea compounds |
| 04/17/2008 | WO2008043839A1 Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders |
| 04/17/2008 | WO2008043829A2 Method for treating hiv-1 infection by the combined administration of nevirapine, tenofovir and emtricitabine |
| 04/17/2008 | WO2008043811A1 Staurosporine derivatives and radiation |
| 04/17/2008 | WO2008043805A1 Medium supplement for virus production |
| 04/17/2008 | WO2008043800A1 Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 04/17/2008 | WO2008043799A1 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound |
| 04/17/2008 | WO2008043791A2 Thiophene derivatives for treating hepatitis c |
| 04/17/2008 | WO2008043789A1 Novel compounds |
| 04/17/2008 | WO2008043788A2 Novel compounds |
| 04/17/2008 | WO2008043775A1 Substituted pyrazinone derivatives for use as a medicine |
| 04/17/2008 | WO2008043759A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 04/17/2008 | WO2008043740A1 Use of lansoprazole for the treatment of frequent heartburn |
| 04/17/2008 | WO2008043733A1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents |
| 04/17/2008 | WO2008043726A1 Sitamaquine tosylate for the treatment of leishmaniasis |
| 04/17/2008 | WO2008043704A1 Hcv nucleoside inhibitor |
| 04/17/2008 | WO2008043698A1 Vinylogous acids derivatives as chymase inhibitors |
| 04/17/2008 | WO2008043576A1 Use of oncolytic viruses and antiangiogenic agents in the treatment of cancer |
| 04/17/2008 | WO2008043567A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 04/17/2008 | WO2008043544A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |